Cell-free DNA profiling in patients with lupus nephritis.

Anna TruszewskaAgnieszka WirkowskaKamila GalaPiotr TruszewskiŁucja Krzemień-OjakAgnieszka Perkowska-PtasińskaKrzysztof MuchaLeszek PączekBartosz Foroncewicz

Published in: Lupus (2020)

We showed that cfDNA profiling may help to distinguish SLE patients with renal involvement and severe disease course from patients with more favorable outcomes. We suggest cfDNA profile a promising SLE biomarker.

Keyphrases

systemic lupus erythematosus
disease activity
single cell
early onset
type diabetes
metabolic syndrome
drug induced
adipose tissue